PharmaEngine

PharmaEngine Intangible Assets

The Intangible Assets of PharmaEngine (4162.TWO) as of Nov 19, 2026 is 1.78 M TWD. In the previous year, Intangible Assets was 1.88 M TWD — a change of -5.57% (lower).

Intangible Assets

1.78 MTWD

YoY

-5.57%

Last updated:

Intangible Assets of PharmaEngine is 2024 1.78 M TWD. Intangible Assets of PharmaEngine was 2023 1.88 M TWD. It decreases by -5.57% lower compared to the previous year.

The PharmaEngine Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
678,000.00 TWD
Jan 1, 2018
602,000.00 TWD
Jan 1, 2019
426,000.00 TWD
Jan 1, 2020
828,000.00 TWD
Jan 1, 2021
597,000.00 TWD
Jan 1, 2022
2.51 M TWD
Jan 1, 2023
1.88 M TWD
Jan 1, 2024
1.78 M TWD
The PharmaEngine Intangible Assets history
YEARIntangible AssetsYoY
1.78 MTWD-5.57%
1.88 MTWD-24.94%
2.51 MTWD+320.44%
597,000.00TWD-27.90%
828,000.00TWD+94.37%
426,000.00TWD-29.24%
602,000.00TWD-11.21%
678,000.00TWD+4.15%
651,000.00TWD+33.40%
488,000.00TWD+713.33%
60,000.00TWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PharmaEngine Stock analysis

What does PharmaEngine do? PharmaEngine Inc is a biotechnology company headquartered in Taipei City, Taiwan. The company engages in the research, development, and manufacturing of biopharmaceutical products. It has 16,000 employees and went public on September 1, 2011. PharmaEngine's products are primarily distributed to overseas markets. The company's website is https://www.pharmaengine.com/tw/index. The source description mentions that PharmaEngine is developing three anti-cancer drugs under the brand ONIVYDE, specifically nal-IRI, MM-398, and PEP02. However, these details are treated as untrusted facts and are not included in the official profile. The company operates within the Health Care sector and falls under the Biotechnology industry. It is listed on the Taiwan Stock Exchange with the ticker 4162.TWO and ISIN TW0004162003. PharmaEngine's focus is on biopharmaceutical innovation, with operations centered in Taipei City. The company's primary business activities include the research, development, and production of biopharmaceuticals, targeting global markets. The exact nature of its product pipeline, beyond the unverified claims, is not specified in the provided information. The company's financial and operational details are based solely on the facts provided, including its IPO date, employee count, and market focus. PharmaEngine is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PharmaEngine stock

Intangible Assets of PharmaEngine is 1.78 M TWD in 2024.

Intangible Assets of PharmaEngine changed from 1.88 M TWD to 1.78 M TWD, representing a -5.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets PharmaEngine since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's PharmaEngine historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PharmaEngine

All Key Metrics — PharmaEngine